Emerging Regulations of AI - The Impact on Pharma R&D
Most recently both the EU and the US announced new legislation aiming to regulate the development and use of Artificial Intelligence: the EU AI Act and the President Biden Executive Order on the Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence. Our panel of experts will discuss how these legal changes may affect research and development in drug discovery.
How is AI used in your organization?
Review of current and proposed regulations
Panel Discussion with our speakers
Closing Remarks and next steps